Status:

UNKNOWN

Comparison Between Calculated Bioavailable Testosterone Level With Radio-immunoassay Result.

Lead Sponsor:

Centre Hospitalier Universitaire, Amiens

Conditions:

Testosterone

Androgens

Eligibility:

All Genders

18-90 years

Brief Summary

Currently, the gold standard to obtain bioavailable testosterone results is radioimmunoassay (RIA). However, this assay requires specific equipment. Giton in 2006 proposed an optimized calculation of...

Eligibility Criteria

Inclusion

  • Every men and women aged between 18 and 90 can be included

Exclusion

  • insufficient sample
  • sample not send for RIA

Key Trial Info

Start Date :

March 11 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 1 2024

Estimated Enrollment :

270 Patients enrolled

Trial Details

Trial ID

NCT04807231

Start Date

March 11 2021

End Date

March 1 2024

Last Update

April 12 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU Amiens

Amiens, France, 80480